Quantitative analysis for Neuberger High Yield Strategies Fund Inc. (NHS) — Financials: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Sell (23.0) (grade F). 26 signals analyzed (23 differentiated alt-data).
NHS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $6.42 | $6.36 | $6.39 |
| 2026-05-11 | $6.49 | $6.45 | $6.47 |
| 2026-05-21 | $6.27 | $6.18 | $6.26 |
| 2026-06-03 | $6.42 | $6.34 | $6.34 |
| 2026-06-15 | $6.29 | $6.26 | $6.27 |
| 2026-06-26 | $6.15 | $6.09 | $6.12 |
| 2026-07-09 | $6.22 | $6.18 | $6.21 |
| 2026-07-21 | $6.14 | $6.11 | $6.12 |
| 2026-07-31 | $6.05 | $5.98 | $6.00 |
| 2026-08-12 | $6.11 | $6.05 | $6.07 |
| 2026-08-24 | $5.97 | $5.93 | $5.96 |
| 2026-09-03 | $5.98 | $5.93 | $5.94 |
How Neuberger High Yield Strategies Fund Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| FIGX | FIGX Capital Acquisition Corp. | $198M | — |
| NTWO | Newbury Street II Acquisition Corp | $191M | — |
| TONX | TON Strategy Co. | $185M | — |
| DHY | Credit Suisse High Yield Bond Fund, Inc. | $184M | — |
View all Financials stocks by valuation and signals →
NHS scores Strong Sell (23.0), resting on a single measured dimension: technicals at 14 out of 100. The remaining dimensions are unmeasured for this ticker rather than weak. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 14 |
StoQuant analyzes 26 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Financials Hub — Top performers and valuation outliers in Financials
Get daily updates on Neuberger High Yield Strategies Fund Inc. (NHS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/NHS"><img src="https://stoquant.com/badge/NHS.svg" alt="Neuberger High Yield Strategies Fund Inc. (NHS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.